When Donald Trump announced his 25% tariffs on steel and aluminum imports, the impact reverberated instantly through the global economic community. The European Union, having fostered robust trade ties with the U.S. for years, found itself compelled to respond. The initial reaction from EU leaders was both swift and strategic, revealing the precarious balance that
0 Comments
The landscape of Alzheimer’s treatment is evolving, with recent approvals for next-generation therapies like lecanemab and donanemab igniting hope among patients and families. However, this optimism is often accompanied by a darker reality: while these drugs promise to manage symptoms by clearing sticky amyloid plaques in the brain, the benefits they furnish can be nuanced
0 Comments